India Pharma Outlook Team | Wednesday, 27 May 2026
Tata Elxsi has launched ViTel, an AI-driven material intelligence solution for medical device manufacturers, co-developed with Viridium AI. The new platform, formally introduced today at DeviceTalks Boston 2026, aims to help MedTech companies make smarter decisions about materials, supply chain, and regulatory compliance.
Medical device makers today face growing challenges. Material choices affect everything from profit margins and supply reliability to how quickly they can launch products and enter new markets. Yet vital information is often scattered across bills of materials, supplier files, ERP and PLM systems, and the minds of experienced team members. This makes every new regulation or customer request a slow and expensive process.
ViTel changes that by creating a single, reusable material intelligence layer across the company. It helps teams quickly spot material and supplier dependencies, check country-of-origin risks, find alternative materials, and understand how certain risks could impact costs, production continuity, or market approvals.
Also Read: Sun Pharma Q4 Revenue Rises 13.6%, Net Profit Jumps 26.2%
Built on Viridium AI’s Knowledge Cloud, Chemical Digital Twin, and science-based AI models, ViTel turns fragmented data into a living knowledge graph. This smart system connects products, parts, materials, chemicals, suppliers, regulations, and evidence in one easy-to-use platform.
What makes ViTel special is Tata Elxsi’s 30 years of hands-on experience in medical technology engineering and regulations. This real-world expertise is built into the system, helping it think through complex material risks, compliance issues, and sourcing decisions more effectively.
Sreevatsa Sahasranaman, Senior Vice President and Head of Healthcare and Life Sciences at Tata Elxsi, said "ViTel brings Material Intelligence directly into the product and compliance workflows that matter most, helping our customers make faster, more confident decisions across sourcing, engineering, quality, and regulatory readiness.”
Niraj Deo, chief executive officer, Viridium AI said, “Viridium AI was built to help manufacturers understand the material DNA of their products. In Med-Tech, that intelligence creates a strategic foundation for the manufacturer. Once product and material knowledge are digitized, it becomes a reusable enterprise asset for margin, sourcing, engineering, quality, and regulatory decisions. Partnering with Tata Elxsi through ViTel brings that capability directly into the hands of the teams who need it most.”
The solution was developed through STEP UP, Tata Elxsi’s program for partnering with promising deep-tech companies. Muthusamy Selvaraj, VP of Innovation and Partnerships at Tata Elxsi’s Healthcare division, shared the thinking behind it: “We asked what the best material intelligence platform could achieve if it was built with a deep understanding of healthcare needs. That question shaped our partnership with Viridium AI.”
As global rules on material transparency, sustainability, and supply chain responsibility continue to tighten, ViTel offers a timely solution. It reduces time spent on manual work, lowers compliance risks, and helps companies bring safer and more sustainable products to market faster.
By combining Tata Elxsi’s strong industry knowledge with Viridium AI’s advanced technology, ViTel stands out as a practical tool that turns raw material data into real business value for medical device manufacturers worldwide.
.jpg)
.jpg)
